“In December 2012, USAID released its new strategy for global health research and development” (R&D), Molly Schmalzbach, public affairs analyst for the Office of HIV/AIDS, writes in USAID’s “IMPACTblog.” “The report outlines how the agency plans to address some of the world’s most challenging health and development issues through new technologies, research and evaluation, and the scale-up of interventions backed by scientific evidence,” she notes, adding, “HIV/AIDS is a large component of this effort and the agency, through [PEPFAR], is supporting very promising HIV research in several areas, including microbicides, vaccines, and diagnostic tools to detect tuberculosis (TB) in HIV-positive patients” (3/5).